BusinessLogrBusinessLogr
  • Home
  • Stocks
  • Finance
  • Business
  • Company
  • Economy
  • Industry
  • Investing
  • Car News
  • Contact Us!
Reading: Halol plant concerns haunt Sun Pharma
Share
Aa
BusinessLogrBusinessLogr
Aa
  • Home
  • Stocks
  • Finance
  • Business
  • Company
  • Economy
  • Industry
  • Investing
  • Car News
  • Contact Us!
Follow US
© 2023 BusinessLogr News Network.
BusinessLogr > Company > Halol plant concerns haunt Sun Pharma
Company

Halol plant concerns haunt Sun Pharma

deep
Last updated: 2015/11/10 at 9:30 AM
deep Published November 10, 2015
Share
3 Min Read
SHARE
Dilip Shanghvi

Dilip Shanghvi
  • ALSO READ

    Supplies from Sun’s Halol facility likely to improve in coming quarters Sun Pharma, SPARC dip as USFDA revokes approval for epilepsy drug Sun Pharma: buy or sell? US FDA revokes approval to Sun Pharma’s anti epilepsy drug No material impact of US court order, says Sun Pharmaceuticals (spot)

The Sun Pharma stock, declining since October 27, touched its 15-month intra-day low of Rs 746, before closing almost six per cent down at Rs 757 on Monday. While Sun had recently warned of a decline in profits due to integration of Ranbaxy, the 46 per cent profit decline in the September quarter was expected. But, the increased concern on Halol plant has unnerved the market.

The Halol plant has been under US Food and Drug Administration (FDA) observations for long now, and the company was seeing stress on fresh approvals for launches filed from the plant. However, news that this plant has got an OAI (Official Action Indicated) indicates higher probability of a warning letter by FDA.

While Sun has informed investors the company has given an original remediation plan for Halol plan to FDA and kept the agency updated on the progress “at great frequency”, with elevated concerns on US business and its potential impact on profits in FY16, analysts have a neutral rating on the stock. Though looking at the synergy benefits after Ranbaxy integration, analysts’ target prices are at Rs 900 and higher, significant upsides in the near-term are unlikely.

Halol plant concerns haunt Sun Pharma

The September quarter results are also far from exciting. Sun’s US sales, which contributed 48 per cent (or $510 million) to overall revenues, declined 28 per cent year-on-year. This was due to competitive pressure on some products, supply constraints at Halol plant and high base of last year’s quarter.

While Sun has other FDA-approved plants, its ability to launch products after getting site-transfer approvals will be looked at keenly by the Street. Analysts at Reliance Securities estimate product sales at $260 million, a 75 per cent Ebitda (earnings before interest, tax, depreciation, and amortisation) margin from its expected launch in February, but uncertainty on other product launches remain. US subsidiary Taro disappointed on volume growth in the September quarter.

India sales, which contribute 26 per cent to revenues, at Rs 1,819 crore, grew one per cent year-on-year in the September quarter. Sun says it was on the back of inventory control, withdrawal of bonus offers, and a relatively soft season in the acute segment. Sun’s stock price is likely to remain under pressure in the near term.

[“source -business-standard”]

You Might Also Like

Freshdesk Introduces Freshsales, CRM with Something Extra

20 Pizza Franchises Challenging Pizza Hut and Domino’s

Shopify Partners with Export Development Canada to Insure Merchant Cash Advances

GoDaddy Sponsors New Seed-Funding TV Show Funderdome

How to Use ClickBank Affiliate Marketing: A Step by Step Guide

TAGGED: Halol plant concerns, haunt Sun Pharma
deep November 10, 2015
Share this Article
Facebook Twitter Email Print
Share
Previous Article Corp Bank net up 17.5% at Rs 189 cr
Next Article Eicher: Royal Enfield growth to moderate

Most Viewed Posts

  • 20 Fitness Franchises: Planet Fitness and Beyond
  • Choosing the Right Legal Structure For Your Business
  • find a loan shark on craigslist
  • bmo harris express loan payment
  • bmo harris bank express loan pay

Most Viewed Posts

  • 20 Fitness Franchises: Planet Fitness and Beyond
  • Choosing the Right Legal Structure For Your Business
  • find a loan shark on craigslist
  • bmo harris express loan payment
  • bmo harris bank express loan pay

Recent Posts

  • Effortlessly Plan Your Loan Payments with TitleMax Loan Payment Calculator
  • Suncoast Loan Payment: Simplifying Your Repayment Process

© 2023 BusinessLogr News Network.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc..

[mc4wp_form]
Zero spam, Unsubscribe at any time.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?